US6100071A
(en)
*
|
1996-05-07 |
2000-08-08 |
Genentech, Inc. |
Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
|
WO1999037772A1
(en)
|
1998-01-23 |
1999-07-29 |
Immunex Corporation |
Il-18 receptors
|
US7083950B2
(en)
*
|
1998-09-25 |
2006-08-01 |
Regeneron Pharmaceuticals, Inc. |
High affinity fusion proteins and therapeutic and diagnostic methods for use
|
US6927044B2
(en)
*
|
1998-09-25 |
2005-08-09 |
Regeneron Pharmaceuticals, Inc. |
IL-1 receptor based cytokine traps
|
US7083949B2
(en)
|
1998-09-25 |
2006-08-01 |
Regeneron Pharmaceuticals, Inc. |
Receptor based antagonists and methods of making and using
|
US20040120891A1
(en)
*
|
1998-12-21 |
2004-06-24 |
Craig Hill |
Compounds for intracellular delivery of therapeutic moieties to nerve cells
|
US20040220103A1
(en)
|
1999-04-19 |
2004-11-04 |
Immunex Corporation |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
EP2292665B1
(en)
|
2000-05-26 |
2015-07-08 |
Immunex Corporation |
Use of interleukin-4 antibodies and compositions thereof
|
AU2001274234A1
(en)
|
2000-06-16 |
2001-12-24 |
Asterion Limited |
Binding agents: chimeric ligand/receptor proteins
|
AU2001290524A1
(en)
|
2000-08-08 |
2002-02-18 |
Zymogenetics Inc. |
Soluble zcytor 11 cytokine receptors
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
US20050112616A1
(en)
*
|
2001-12-10 |
2005-05-26 |
William Lee |
Functionalized materials and libraries thereof
|
US7795213B2
(en)
*
|
2001-12-13 |
2010-09-14 |
Posco |
Methods of contacting β amyloid protein with VEGF
|
US6846520B2
(en)
*
|
2002-01-17 |
2005-01-25 |
Canon Kabushiki Kaisha |
Epoxy resin composition, surface treatment method, liquid-jet recording head and liquid-jet recording apparatus
|
AU2003243189B2
(en)
|
2002-05-01 |
2008-01-24 |
Regeneron Pharmaceuticals, Inc. |
Methods of using cytokine antagonists to treat HIV infection and AIDS
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
KR101329843B1
(ko)
*
|
2002-11-15 |
2013-11-14 |
젠맵 에이/에스 |
Cd25에 대한 인간 모노클로날 항체
|
US6919012B1
(en)
|
2003-03-25 |
2005-07-19 |
Olimex Group, Inc. |
Method of making a composite article comprising a ceramic coating
|
ES2327409T3
(es)
|
2003-03-26 |
2009-10-29 |
Apogenix Gmbh |
Proteinas de fusion fc mejoradas.
|
WO2004100987A2
(en)
*
|
2003-05-06 |
2004-11-25 |
Regeneron Pharmaceuticals, Inc. |
Methods of using il-1 antagonists to treat neointimal hyperplasia
|
WO2004098596A1
(en)
*
|
2003-05-12 |
2004-11-18 |
Altana Pharma Ag |
Composition comprising roflumilast and il-1 trap
|
EP1664114A1
(en)
*
|
2003-06-11 |
2006-06-07 |
Wyeth |
Method for producing a polypeptide
|
SI1648940T1
(sl)
*
|
2003-07-28 |
2016-08-31 |
Genentech, Inc. |
Zmanjševanje izluževanja proteina A med afinitetno kromatografijo proteina A
|
WO2005024035A1
(en)
*
|
2003-09-05 |
2005-03-17 |
National Research Council Of Canada |
Coiled-coil fusion proteins comprising cell receptor domains
|
ATE548388T1
(de)
|
2003-11-07 |
2012-03-15 |
Immunex Corp |
An den interleukin-4-rezeptor bindende antikörper
|
ATE395358T1
(de)
*
|
2004-02-27 |
2008-05-15 |
Regeneron Pharma |
Il-4/il-13-spezifische polypetide und deren therapeutische verwendung
|
MXPA06014126A
(es)
|
2004-06-04 |
2007-07-18 |
Regeneron Pharma |
Metodos para utilizar antagonistas il-1 para tratar enfermedades auto-inflamatorias.
|
DK2332977T3
(da)
|
2004-07-23 |
2016-02-29 |
Acceleron Pharma Inc |
ActRII-receptorpolypeptider
|
PL1778723T3
(pl)
*
|
2004-08-17 |
2013-03-29 |
Regeneron Pharma |
Preparaty antagonisty IL-1
|
ES2309427T3
(es)
*
|
2004-08-27 |
2008-12-16 |
Conaris Research Institute Ag |
Secuencias de nucleotidos optimizidas que codifican para sgp130.
|
US7786261B2
(en)
*
|
2004-09-02 |
2010-08-31 |
National Research Council Of Canada |
Coiled-coil fusion proteins comprising cell receptor domains
|
WO2006031689A2
(en)
*
|
2004-09-13 |
2006-03-23 |
Genzyme Corporation |
Multimeric constructs
|
RU2007117716A
(ru)
*
|
2004-10-12 |
2008-11-20 |
Ампротеин Корпорейшн (Us) |
Химерный белок
|
EP1812476B1
(en)
|
2004-10-22 |
2010-07-21 |
ZymoGenetics, Inc. |
Anti-il-22ra antibodies and binding partners and methods of using in inflammation
|
EP1848738A1
(en)
*
|
2005-01-25 |
2007-10-31 |
Apollo Life Sciences Limited |
Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes
|
EP3195874A1
(en)
*
|
2005-03-25 |
2017-07-26 |
Regeneron Pharmaceuticals, Inc. |
Vegf antagonist formulations
|
US7732167B2
(en)
*
|
2005-06-17 |
2010-06-08 |
Regeneron Pharmaceuticals, Inc. |
Interferon-α/β binding fusion proteins and therapeutic uses thereof
|
US7608430B2
(en)
*
|
2005-07-08 |
2009-10-27 |
Regeneron Pharmaceuticals, Inc. |
Interferon-γ antagonists and therapeutic uses thereof
|
EP1912675B1
(en)
|
2005-07-25 |
2014-02-12 |
Emergent Product Development Seattle, LLC |
B-cell reduction using cd37-specific and cd20-specific binding molecules
|
US7666622B2
(en)
*
|
2005-10-19 |
2010-02-23 |
Regeneron Pharmaceuticals, Inc. |
Monomeric self-associating fusion polypeptides and therapeutic uses thereof
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
US7889347B2
(en)
|
2005-11-21 |
2011-02-15 |
Plexera Llc |
Surface plasmon resonance spectrometer with an actuator driven angle scanning mechanism
|
EP3811965A1
(en)
|
2005-11-23 |
2021-04-28 |
Acceleron Pharma, Inc. |
Activin-actriia antagonists in use for promoting bone growth
|
US8128933B2
(en)
|
2005-11-23 |
2012-03-06 |
Acceleron Pharma, Inc. |
Method of promoting bone growth by an anti-activin B antibody
|
US7463358B2
(en)
|
2005-12-06 |
2008-12-09 |
Lumera Corporation |
Highly stable surface plasmon resonance plates, microarrays, and methods
|
WO2007110205A2
(en)
|
2006-03-24 |
2007-10-04 |
Merck Patent Gmbh |
Engineered heterodimeric protein domains
|
US8409577B2
(en)
|
2006-06-12 |
2013-04-02 |
Emergent Product Development Seattle, Llc |
Single chain multivalent binding proteins with effector function
|
EP2364691B1
(en)
|
2006-06-16 |
2013-04-24 |
Regeneron Pharmaceuticals, Inc. |
VEGF antagonist formulations suitable for intravitreal administration
|
RS51544B
(en)
|
2006-06-30 |
2011-06-30 |
Conaris Research Institute Ag. |
POBOLJŠANI SGP 130FC DIMERI
|
US7666423B2
(en)
|
2006-07-28 |
2010-02-23 |
Children's Memorial Hospital |
Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
|
US8106004B2
(en)
*
|
2006-07-28 |
2012-01-31 |
Children's Memorial Hospital |
Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
|
RS52538B
(en)
*
|
2006-10-20 |
2013-04-30 |
Regeneron Pharmaceuticals Inc. |
USE OF IL-1 ANTAGONISTS FOR THE TREATMENT OF GYTH AND PSEUDOGYCH
|
US7632490B2
(en)
*
|
2006-10-20 |
2009-12-15 |
Regeneron Pharmaceuticals, Inc. |
Use of IL-1 antagonists to treat gout
|
US8895016B2
(en)
|
2006-12-18 |
2014-11-25 |
Acceleron Pharma, Inc. |
Antagonists of activin-actriia and uses for increasing red blood cell levels
|
WO2008093756A1
(ja)
*
|
2007-01-30 |
2008-08-07 |
Niigata University |
生物学的製剤
|
ES2415666T3
(es)
|
2007-02-01 |
2013-07-26 |
Acceleron Pharma, Inc. |
Composiciones farmacéuticas que comprenden antagonistas de Activina-ActRIIa para uso en la prevención o el tratamiento de metástasis de cáncer de mama o pérdida ósea relacionada con el cáncer de mama
|
TW202104248A
(zh)
|
2007-02-02 |
2021-02-01 |
美商艾瑟勒朗法瑪公司 |
衍生自ActRIIB的變體與其用途
|
TW201934141A
(zh)
|
2007-02-09 |
2019-09-01 |
美商艾瑟勒朗法瑪公司 |
包含ActRIIa-Fc融合蛋白的醫藥組合物;ActRIIa-Fc融合蛋白於治療或預防與癌症相關的骨質流失之用途;ActRIIa-Fc融合蛋白於治療或預防多發性骨髓瘤之用途
|
TWI573802B
(zh)
|
2007-03-06 |
2017-03-11 |
安美基公司 |
變異之活動素受體多肽及其用途
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
WO2008113185A1
(en)
*
|
2007-03-19 |
2008-09-25 |
National Research Counsil Of Canada |
Antagonists of ligands and uses thereof
|
WO2009010539A2
(en)
*
|
2007-07-19 |
2009-01-22 |
Ablynx. N.V. |
Receptor for interleukin-6 (il-6) from macaca fascicularis
|
EP2207562B1
(en)
|
2007-09-18 |
2017-05-31 |
Acceleron Pharma, Inc. |
Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
|
WO2009058888A1
(en)
*
|
2007-10-31 |
2009-05-07 |
The Scripps Research Institute |
Combination therapy to treat persistent viral infections
|
US8004669B1
(en)
|
2007-12-18 |
2011-08-23 |
Plexera Llc |
SPR apparatus with a high performance fluid delivery system
|
JP6013733B2
(ja)
|
2008-04-11 |
2016-10-25 |
エマージェント プロダクト デベロップメント シアトル, エルエルシー |
Cd37免疫治療薬および二機能性化学療法薬とのその組合せ
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
PL2340031T4
(pl)
|
2008-08-14 |
2020-12-28 |
Acceleron Pharma Inc. |
Zastosowanie pułapek GDF do leczenia niedokrwistości
|
EP2326670A4
(en)
*
|
2008-09-17 |
2014-04-16 |
Nat Res Council Canada |
HETERO MULTIVALENT BINDING AGENT FOR ELEMENTS OF THE TGF-BETA SUPERFAMILY
|
AU2009320364B2
(en)
|
2008-11-26 |
2013-05-16 |
Amgen Inc. |
Variants of activin IIB receptor polypeptides and uses thereof
|
MX355042B
(es)
|
2009-06-08 |
2018-04-02 |
Acceleon Pharma Inc |
Metodos para aumentar adipositos termogenicos.
|
EP2440577A4
(en)
|
2009-06-12 |
2013-01-23 |
Acceleron Pharma Inc |
SHORTEN ACTRIIB FC FUSION PROTEINS
|
CA2781152A1
(en)
|
2009-11-17 |
2011-05-26 |
Acceleron Pharma Inc. |
Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
|
WO2012064771A1
(en)
|
2010-11-08 |
2012-05-18 |
Acceleron Pharma, Inc. |
Actriia binding agents and uses thereof
|
AU2012242666A1
(en)
|
2011-04-15 |
2013-11-28 |
Merck Patent Gmbh |
Anti- IL-1R1 inhibitors for use in cancer
|
JO3283B1
(ar)
|
2011-04-26 |
2018-09-16 |
Sanofi Sa |
تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
|
SG11201403367YA
(en)
|
2011-12-19 |
2014-07-30 |
Amgen Inc |
Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
|
ES2884095T3
(es)
|
2012-11-02 |
2021-12-10 |
Celgene Corp |
Antagonistas de activina-actrii y usos para el tratamiento de trastornos óseos y otros trastornos
|
AU2013357427B2
(en)
*
|
2012-12-10 |
2017-08-31 |
Universiteit Gent |
Novel Interleukin-33 inhibitors
|
EP3985024A1
(en)
|
2013-02-01 |
2022-04-20 |
Atara Biotherapeutics, Inc. |
Anti-activin-a compounds for the treatment of ovarian cancer
|
LT2956471T
(lt)
|
2013-02-15 |
2024-06-10 |
R-Pharm International, Llc |
Il-1beta inhibitoriaus kompozicija ir jos naudojimas
|
CN114699529A
(zh)
|
2014-06-13 |
2022-07-05 |
阿塞勒隆制药公司 |
用于治疗溃疡的方法和组合物
|
TR201909951T4
(tr)
|
2014-07-18 |
2019-07-22 |
Sanofi Sa |
Kanser olduğundan şüphelenilen bir hastanın aflibersept ile tedavisinin sonucunun öngörülmesine yönelik yöntem.
|
MA41052A
(fr)
|
2014-10-09 |
2017-08-15 |
Celgene Corp |
Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
|
MA41116A
(fr)
|
2014-12-01 |
2017-10-10 |
Ferring Bv |
Compositions d'inhibiteur de trans-signalisation par l'il-6 sélectif
|
EP3226888B1
(en)
|
2014-12-01 |
2021-04-21 |
Ferring B.V. |
Administration of a selective il-6-trans-signalling inhibitor
|
SI3227675T1
(sl)
|
2014-12-03 |
2023-07-31 |
Celgene Corporation |
Antagonisti aktivin-actrii in uporaba za zdravljenje mielodisplastičnega sindroma
|
GB201503453D0
(en)
|
2015-03-01 |
2015-04-15 |
Jain Arjun |
Endothelin-1"sponge"
|
JP7240812B2
(ja)
*
|
2015-05-12 |
2023-03-16 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
多量体タンパク質の純度の決定
|
KR20180053322A
(ko)
|
2015-09-21 |
2018-05-21 |
압테보 리서치 앤드 디벨롭먼트 엘엘씨 |
Cd3 결합 폴리펩타이드
|
CN118307682A
(zh)
|
2016-09-27 |
2024-07-09 |
埃皮辛特瑞柯斯公司 |
免疫调节性融合蛋白
|
BR112019021812A2
(pt)
|
2017-04-21 |
2020-05-26 |
Kindred Biosciences, Inc. |
Molécula receptora de il4/il13 para uso veterinário
|
CA3077223A1
(en)
|
2017-09-27 |
2019-04-04 |
Epicentrx, Inc. |
Immunomodulatory fusion proteins
|
EA202091710A1
(ru)
|
2018-03-09 |
2021-02-16 |
Агенус Инк. |
Антитела против cd73 и способы их применения
|
WO2020018700A1
(en)
|
2018-07-18 |
2020-01-23 |
Manzanita Pharmaceuticals, Inc. |
Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
|
CN110950965B
(zh)
*
|
2018-09-26 |
2021-10-15 |
重庆精准生物技术有限公司 |
抗人cd123的嵌合抗原受体及其应用
|